MoneyWorks4Me

Sandu Pharmaceuticals informs about issuance of duplicate share certificate

18 Dec 2020 Evaluate

Pursuant to regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 Sandu Pharmaceuticals has informed about the issue of the duplicate share certificate to the shareholder(s), Rukmanibai Tillumak Manghnan (Folio No: 000236, 000266). Further details of the same as enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..